Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-26T02:17:50.849Z Has data issue: false hasContentIssue false

15 - Early clinical features of the parkinsonian-related dementias

Published online by Cambridge University Press:  31 July 2009

Bruce L. Miller
Affiliation:
University of California, San Francisco
Bradley F. Boeve
Affiliation:
Mayo Foundation, Minnesota
Get access

Summary

Introduction

Neurologists are confronted with complex patients in whom accurate diagnoses and improvement of symptoms are expected. One useful strategy is to determine if a patient has a constellation of symptoms and findings that fits within a broad category or syndrome, which then narrows the differential diagnosis and allows the clinician to commence a focused work-up. For example, the differential diagnosis and spectrum of available diagnostic studies for a patient with dementia, or a patient with parkinsonism, are rather wide; these are far more restricted in those who have elements of both dementia and parkinsonism. Furthermore, an insidious onset and progressive course suggests a neurodegenerative disease as the likely underlying process. This scenario is relatively common for community neurologists and very common for behavioral neurology and movement disorder specialists at academic centers.

The primary differential diagnosis in a patient with dementia plus parkinsonism who has experienced an insidious onset and progressive course, in probable decreasing prevalence in the population, includes dementia with Lewy bodies (DLB), Parkinson's disease (PD) with dementia (PDD), progressive supranuclear palsy (PSP), corticobasal syndrome (CBS)/corticobasal degeneration (CBD), and frontotemporal dementia (FTD) with parkinsonism linked to chromosome 17 (FTDP-17). One useful exercise in the clinic is to use the interview and examination to explore the following areas of symptomatology: cognitive/neuropsychological, behavioral/neuropsychiatric, motor/ extrapyramidal, sleep, autonomic, sensory and other/miscellaneous features. In typical cases, these clinical features permit relatively easy differentiation (Table 15.1).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dickson, D. Dementia with Lewy bodies: neuropathology. J Geriatr Psychiatr Neurol. 2002;15:210–216.CrossRefGoogle ScholarPubMed
Apaydin, H, Ahlskog, J, Parisi, Jet al. Parkinson's disease neuropathology: later-developing dementia and loss of the Levodopa response. Arch Neurol. 2002;59:102–112.CrossRefGoogle ScholarPubMed
Tsuboi, Y, Dickson, D.Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?Park Relat Disord. 2005;11:S47–S51.CrossRefGoogle ScholarPubMed
McKeith, I, Dickson, D, Lowe, Jet al. Dementia with Lewy bodies: diagnosis and management: Third report of the DLB Consortium. Neurology. 2005;65:1863–1872.CrossRefGoogle ScholarPubMed
Knopman, D, Boeve, B, Petersen, R. Essentials of the proper diagnosis of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc. 2003;78:1290–1308.CrossRefGoogle Scholar
Boeve, B. Dementia with Lewy Bodies. In Petersen, R (ed.) Continuum, Vol. 10. Minneapolis: American Academy of Neurology, 2004:81–112.Google Scholar
Boeve, B, Silber, M, Saper, Cet al. Pathophysiology of REM sleep behavior disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–2788.CrossRefGoogle ScholarPubMed
Ferman, T, Smith, G, Boeve, Bet al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol. 2006;20:623–636.CrossRefGoogle ScholarPubMed
Simard, M, Reekum, R, Cohen, T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatr Clin Neurosci. 2000;12:425–450.CrossRefGoogle ScholarPubMed
Arnulf, I, Bonnet, AM, Damier, Pet al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology. 2000;55:281–288.CrossRefGoogle ScholarPubMed
Boeve, B, Silber, M, Parisi, Jet al. Neuropathologic findings in patients with REM sleep behavior disorder and a neurodegenerative disorder. Neurology. 2001;56:A299.Google Scholar
Boeve, B, Silber, M, Ferman, Tet al. REM sleep behavior disorder in Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. In Bedard, M, Agid, Y, Chouinard, Set al. (eds.) Mental and Behavioral Dysfunction in Movement Disorders. Totowa, NJ: Humana Press, 2003:383–397.CrossRefGoogle Scholar
Aarsland, D, Ballard, C, Larsen, J, McKeith, I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry. 2001;16:528–536.CrossRefGoogle ScholarPubMed
Marantz, A, Verghese, J. Capgras' syndrome in dementia with Lewy bodies. J Geriatr Psychiatr Neurol. 2002;15:239–241.CrossRefGoogle ScholarPubMed
Boeve, B, Silber, M, Ferman, Tet al. Association of REM sleep behavior disorder and neurodegenerative disease. Sleep. 1999;22(Suppl 1):S72.Google Scholar
Boeve, B, Silber, M, Ferman, Tet al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord. 2001;16:622–630.CrossRefGoogle ScholarPubMed
Boeve, B, Silber, M, Ferman, T. Current management of sleep disturbances in dementia. Cur Neurol Neurosci Rep. 2001;2:169–177.CrossRefGoogle Scholar
Ballard, C, Shaw, F, McKeith, I, Kenny, R. High prevalence of neurovascular instability in neurodegenerative dementias. Neurology. 1998;51:1760–1762.CrossRefGoogle ScholarPubMed
Hishikawa, N, Hashizume, Y, Yoshida, M, Sobue, G. Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathol (Berl). 2003;105:341–350.Google ScholarPubMed
Thaisetthawatkul, P, Boeve, B, Benarroch, Eet al. Autonomic dysfunction in dementia with Lewy bodies. Neurology. 2004;62:1804–1809.CrossRefGoogle ScholarPubMed
Pakiam, AS, Bergeron, C, Lang, AE. Diffuse Lewy body disease presenting as multiple system atrophy. Can J Neurol Sci. 1999;26:127–131.Google ScholarPubMed
Hawkes, C, Del Tredici, K, Braak, H. Parkinson's disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33:599–614.CrossRefGoogle ScholarPubMed
Walker, Z, Stevens, T. Dementia with Lewy bodies: clinical characteristics and diagnostic criteria. J Geriatr Psychiatry Neurol. 2002;15:188–194.CrossRefGoogle ScholarPubMed
Walker, M, Ayre, G, Cummings, Jet al. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry. 2000;177:252–256.CrossRefGoogle ScholarPubMed
Walker, M, Ayre, G, Cummings, Jet al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology. 2000;54:1616–1625.CrossRefGoogle ScholarPubMed
Walker, M, Ayre, G, Perry, Eet al. Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dem Geriatr Cog Disord. 2000;11:327–335.CrossRefGoogle ScholarPubMed
Ferman, T, Smith, G, Boeve, Bet al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62:181–187.CrossRefGoogle ScholarPubMed
Emre, M, Aarsland, D, Brown, Ret al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22:1689–1707.CrossRefGoogle ScholarPubMed
Gjerstad, M, Boeve, B, Wentzel-Larsen, Tet al. Occurrence and clinical correlates of REM sleep behavior disorder in patients with Parkinson's disease over time. J Neurol Neurosurg Psychiatry. 2008; 79(4); 387–391.CrossRefGoogle ScholarPubMed
Fronczek, R, Overeem, S, Lee, Set al. Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007;130:1577–1585.CrossRefGoogle ScholarPubMed
Thannickal, T, Lai, Y, Siegel, J. Hypocretin (orexin) cell loss in Parkinson's disease. Brain. 2007;130:1586–1595.CrossRefGoogle ScholarPubMed
Boeve, B, Silber, M, Ferman, T. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Ger Psychiatr Neurol. 2004;17:146–157.CrossRefGoogle ScholarPubMed
Boeve, B, Silber, M. Sleep Disturbances in Parkinson's disease. In Martine, R, Duda, J (eds.) Parkinson Disease: Mind, Mood, and Memory. Miami, FL:National Parkinson Foundation, 2005:54–71.Google Scholar
Boeve, B, Ferman, T, Smith, Get al. Mild cognitive impairment preceding dementia with Lewy bodies. Neurology. 2004;62:A86–A87.Google Scholar
Caviness, J, Driver-Dunckley, E, Connor, Det al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007;22:1272–1277.CrossRefGoogle ScholarPubMed
Petersen, R. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–194.CrossRefGoogle ScholarPubMed
Postuma, R, Lang, A, Massicotte-Marquez, J, Montplaisir, J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006;66:845–851.CrossRefGoogle ScholarPubMed
Boeve, B, Saper, C. REM sleep behavior disorder: a possible early marker for synucleinopathies. Neurology. 2006;66:796–797.CrossRefGoogle ScholarPubMed
Boeve, B, Dickson, D, Olson, Eet al. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 2007; 8:60–64.CrossRefGoogle ScholarPubMed
Fantini, ML, Gagnon, JF, Petit, Det al. Slowing of electroencephalogram in rapid eye movement sleep behavior disorder. Ann Neurol. 2003;53:774–780.CrossRefGoogle ScholarPubMed
Massicotte-Marquez, J, Carrier, J, Decary, Aet al. Slow-wave sleep and delta power in rapid eye movement sleep behavior disorder. Ann Neurol. 2005;57:277–282.CrossRefGoogle ScholarPubMed
Eisensehr, I, Linke, R, Noachtar, Set al. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder: comparison with Parkinson's disease and controls. Brain. 2000;123:1155–1160.CrossRefGoogle ScholarPubMed
Eisensehr, I, Linke, R, Tatsch, Ket al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep. 2003;26:507–512.CrossRefGoogle ScholarPubMed
Mazza, S, Soucy, J, Gravel, Pet al. Assessing whole brain perfusion changes in REM sleep behavior disorder. Neurology. 2006;67:1618–1622.CrossRefGoogle ScholarPubMed
Caselli, R, Chen, K, Bandy, Det al. A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior. Sleep. 2006;29:927–933.CrossRefGoogle ScholarPubMed
Ferini-Strambi, L, Di Gioia, M, Castronovo, Vet al. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist?Neurology. 2004;62:41–45.CrossRefGoogle ScholarPubMed
Stiasny-Kolster, K, Doerr, Y, Möller, Jet al. Combination of “idiopathic” REM sleep behavior disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2005;128:126–137.CrossRefGoogle ScholarPubMed
Ferini-Strambi, L, Oldani, A, Zucconi, M, Smirne, S. Cardiac autonomic activity during wakefulness and sleep in REM sleep behavior disorder. Sleep. 1996;19:367–369.CrossRefGoogle ScholarPubMed
Abbott, R, Ross, G, White, Let al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology. 2005;65:1442–1446.CrossRefGoogle ScholarPubMed
Oka, H, Yoshioka, M, Morita, Met al. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease. Neurology. 2007;69:1460–1465.CrossRefGoogle ScholarPubMed
Miyamoto, T, Miyamoto, M, Inoue, Yet al. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236–2238.CrossRefGoogle ScholarPubMed
Braak, H, Ghebremedhin, E, Rub, Uet al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004;318:121–134.CrossRefGoogle ScholarPubMed
Maurage, C, Ruchoux, M, Vos, Ret al. Retinal involvement in dementia with Lewy bodies: a clue to hallucinations?Ann Neurol. 2003;54:542–547.CrossRefGoogle ScholarPubMed
Litvan, I, Agid, Y, Calne, Det al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS–SPSP International Workshop. Neurology. 1996;47:1–9.CrossRefGoogle Scholar
Josephs, K, Duffy, J, Strand, Eet al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006;129:1385–1398.CrossRefGoogle ScholarPubMed
Josephs, K, Boeve, B, Duffy, Jet al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase. 2005;11:283–296.CrossRefGoogle ScholarPubMed
Dubois, B, Pillon, B, Legault, Fet al. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Arch Neurol. 1988;45:1194–1199.CrossRefGoogle ScholarPubMed
Pillon, B, Deweer, B, Michon, Aet al. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases. Neurology. 1994;44:1264–1270.CrossRefGoogle ScholarPubMed
Pillon, B, Blin, J, Vidailhet, Met al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology. 1995;45:1477–1483.CrossRefGoogle ScholarPubMed
Bak, T, Crawford, L, Hearn, Vet al. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase. 2005;11:268–273.CrossRefGoogle Scholar
Rippon, G, Boeve, B, Parisi, Jet al. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology. Neurocase. 2005;11:204–211.CrossRefGoogle ScholarPubMed
Arnulf, I, Merino-Andreu, M, Bloch, Fet al. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep. 2005;28:349–354.Google ScholarPubMed
Karnik, N, D'Apuzzo, M, Greicius, M. Non-fluent progressive aphasia, depression, and OCD in a woman with progressive supranuclear palsy: neuroanatomical and neuropathological correlations. Neurocase. 2006;12:332–338.CrossRefGoogle Scholar
Boeve, B. Corticobasal degeneration. In Adler, C, Ahlskog, J (eds.) Parkinson's Disease and Movement Disorders: Diagnosis and Treatment Guidelines for the Practicing Physician. Totawa, NJ: Human Press, 2000:253–261.Google Scholar
Boeve, B, Lang, A, Litvan, I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54:S15–S19.CrossRefGoogle ScholarPubMed
Boeve, B. Corticobasal degeneration: the syndrome and the disease. In Litvan, I (ed.) Atypical Parkinsonian Disorders. Totawa, NJ: Humana Press, 2005:309–334.CrossRefGoogle Scholar
Schneider, J, Watts, R, Gearing, Met al. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997;48:959–969.CrossRefGoogle ScholarPubMed
Boeve, BF, Maraganore, DM, Parisi, JEet al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology. 1999;53:795–800.CrossRefGoogle ScholarPubMed
Massman, P, Kreiter, K, Jankovic, J, Doody, R. Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology. 1996;46:720–726.CrossRefGoogle ScholarPubMed
Lehman, M, Duffy, J, Boeve, Bet al. Speech and language disorders associated with corticobasal degeneration. J Med Speech-Lang Pathol. 2003;11:131–146.Google Scholar
Cummings, J, Litvan, I. Neuropsychiatric aspects of corticobasal degeneration. In Litvan, I, Goetz, C, Lang, A (eds.) Corticobasal Degeneration and Related Disorders, Vol. 82. London: Lippincott, Williams & Wilkins, 2000:147–152.Google Scholar
Geda, Y, Boeve, B, Negash, Set al. Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci. 2007;19:77–80.CrossRefGoogle ScholarPubMed
Hutton, M, Lendon, CL, Rizzu, Pet al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702–705.CrossRefGoogle ScholarPubMed
Baker, M, Mackenzie, I, Pickering-Brown, Set al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916–919.CrossRefGoogle ScholarPubMed
Poorkaj, P, Grossman, M, Steinbart, Eet al. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol. 2001;58:383–387.CrossRefGoogle ScholarPubMed
Microtubule-associated protein tau; MAPT http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=157140.
Benussi, L, Binetti, G, Sina, Eet al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 2008;29:427–435.CrossRefGoogle ScholarPubMed
Boeve, B, Baker, M, Dickson, Det al. Frontotemporal dementia and parkinsonism associated with the IVS1+1G→A mutation in progranulin: a clinicopathologic study. Brain. 2006;129:3103–3114.CrossRefGoogle ScholarPubMed
Cruts, M, Gijselinck, I, Zee, Jet al. Null mutations in progranulin cause ubiquitin positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920–924.CrossRefGoogle ScholarPubMed
Gass, J, Cannon, A, Mackenzie, Iet al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15:2988–3001.CrossRefGoogle ScholarPubMed
Huey, ED, Grafman, J, Wassermann, EMet al. Characteristics of frontotemporal dementia patients with a progranulin mutation. Ann Neurol. 2006;60:374–380.CrossRefGoogle ScholarPubMed
Mackenzie, I, Baker, M, Pickering-Brown, Set al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006;129:3081–3090.CrossRefGoogle ScholarPubMed
Masellis, M, Momeni, P, Meschino, Wet al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain. 2006;129:3115–3123.CrossRefGoogle ScholarPubMed
Mukherjee, O, Pastor, P, Cairns, NJet al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol. 2006;60:314–322.CrossRefGoogle ScholarPubMed
Pickering-Brown, S, Baker, M, Gass, Jet al. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain. 2006;129:3124–3126.CrossRefGoogle ScholarPubMed
Snowden, J, Pickering-Brown, S, Mackenzie, Iet al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129:3091–3102.CrossRefGoogle ScholarPubMed
Neumann, M, Sampathu, D, Kwong, Let al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–133.CrossRefGoogle ScholarPubMed
Geschwind, DH, Robidoux, J, Alarcon, Met al. Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia. Ann Neurol. 2001;50:741–746.CrossRefGoogle ScholarPubMed
Ferman, TJ, McRae, CA, Arvanitakis, Zet al. Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. Park Relat Disord. 2003;9:265–270.CrossRefGoogle ScholarPubMed
Frank, A, Wszolek, Z, Jack CR, J, Boeve, B. Distinctive MRI findings in pallido-ponto-nigral degeneration (PPND). Neurology. 2007;68:620–621.CrossRefGoogle Scholar
Miller, BL, Boone, K, Cummings, JLet al. Functional correlates of musical and visual ability in frontotemporal dementia. Br J Psychiatry. 2000;176:458–463.CrossRefGoogle ScholarPubMed
Miller, BL, Seeley, WW, Mychack, Pet al. Neuroanatomy of the self: evidence from patients with frontotemporal dementia. Neurology. 2001;57:817–821.CrossRefGoogle ScholarPubMed
Miller, BL, Diehl, J, Freedman, Met al. International approaches to frontotemporal dementia diagnosis: from social cognition to neuropsychology. Ann Neurol. 2003;54:S7–S10.CrossRefGoogle ScholarPubMed
Rankin, KP, Kramer, JH, Mychack, P, Miller, BL. Double dissociation of social functioning in frontotemporal dementia. Neurology. 2003;60:266–271.CrossRefGoogle ScholarPubMed
Hodges, JR. Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology. 2001;56:S6–S10.CrossRefGoogle ScholarPubMed
Woolley, J, Gorno-Tempini, M, Seeley, Wet al. Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology. 2007;69:1424–1433.CrossRefGoogle ScholarPubMed
Arvanitakis, Z, Witte, R, Dickson, Det al. Clinical–pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Park Relat Disord. 2007;13:230–239.CrossRefGoogle Scholar
Boeve, B, Tremont-Lukats, I, Waclawik, Aet al. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain. 2005;128:752–772.CrossRefGoogle ScholarPubMed
Boeve, B, Lin, S-C, Strongosky, Aet al. Absence of REM sleep behavior disorder in eleven members of the PPND kindred. Arch Neurol. 2006;63:268–272.CrossRefGoogle Scholar
Cheshire, WP, Tsuboi, Y, Wszolek, ZK. Physiologic assessment of autonomic dysfunction in pallidopontonigral degeneration with N279K mutation in the tau gene on chromosome 17. Autonom Neurosci Basic Clin. 2002;102:71–77.CrossRefGoogle ScholarPubMed
Wszolek, ZK, Lagerlund, TD, Steg, RE, McManis, PG. Clinical neurophysiologic findings in patients with rapidly progressive familial parkinsonism and dementia with pallido-ponto-nigral degeneration. Electroenceph Clin Neurophysiol. 1998;107:213–222.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×